OMGMed: Advanced System for Ocular Myasthenia Gravis Diagnosis via Eye Image Segmentation

Author:

Li Jianqiang1,Zhu Chujie1,Zhao Mingming2,Xu Xi1,Zhao Linna1,Cheng Wenxiu1,Liu Suqin1,Zou Jingchen1,Yang Ji-Jiang3ORCID,Yin Jian2

Affiliation:

1. Faculty of Information Technology, Beijing University of Technology, Beijing 100124, China

2. Department of Neurology, Beijing Hospital, Beijing 100730, China

3. Tsinghua National Laboratory for Information Science and Technology, Tsinghua University, Beijing 100084, China

Abstract

This paper presents an eye image segmentation-based computer-aided system for automatic diagnosis of ocular myasthenia gravis (OMG), called OMGMed. It provides great potential to effectively liberate the diagnostic efficiency of expert doctors (the scarce resources) and reduces the cost of healthcare treatment for diagnosed patients, making it possible to disseminate high-quality myasthenia gravis healthcare to under-developed areas. The system is composed of data pre-processing, indicator calculation, and automatic OMG scoring. Building upon this framework, an empirical study on the eye segmentation algorithm is conducted. It further optimizes the algorithm from the perspectives of “network structure” and “loss function”, and experimentally verifies the effectiveness of the hybrid loss function. The results show that the combination of “nnUNet” network structure and “Cross-Entropy + Iou + Boundary” hybrid loss function can achieve the best segmentation performance, and its MIOU on the public and private myasthenia gravis datasets reaches 82.1% and 83.7%, respectively. The research has been used in expert centers. The pilot study demonstrates that our research on eye image segmentation for OMG diagnosis is very helpful in improving the healthcare quality of expert doctors. We believe that this work can serve as an important reference for the development of a similar auxiliary diagnosis system and contribute to the healthy development of proactive healthcare services.

Funder

National High Level Hospital Clinical Research Funding

Publisher

MDPI AG

Reference44 articles.

1. (2024, March 16). Global Myasthenia Gravis Therapeutics Market Size Status and Manufacturers Analysis. Available online: https://www.sohu.com/a/548235609_372052.

2. Assessing facial weakness in myasthenia gravis with facial recognition software and deep learning;Ruiter;Ann. Clin. Transl. Neurol.,2023

3. Update on myasthenia gravis;Thanvi;Postgrad. Med. J.,2004

4. Medical treatment options for ocular myasthenia gravis;Eggenberger;Curr. Opin. Ophthalmol.,2008

5. Ocular myasthenia gravis: A review;Nair;Indian J. Ophthalmol.,2014

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3